BioCryst Pharmaceuticals Congress Trades
NASDAQ: BCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2
- Sales
- 0
- Politicians trading
- 1
- Latest trade
- Jul 10, 2026
BioCryst Pharmaceuticals Congress trading summary
Members of Congress have disclosed 5 transactions in BioCryst Pharmaceuticals (BCRX) stock, reported by 2 politicians. Over the past 12 months there were 2 purchases and 0 sales. The most active trader over the past year is Rep. Gilbert Ray Cisneros, Jr. (2).
The latest reported trade is a purchase by Gilbert Ray Cisneros, Jr. dated Jul 10, 2026 and disclosed on Sep 4, 2026. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading BCRX
BCRX trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
| Buy | $1,001 – $15,000 | Jul 10, 2026 | Filing for Gilbert Ray Cisneros, Jr. BCRX trade | |
| Buy | $1,001 – $15,000 | Nov 13, 2025 | Filing for Gilbert Ray Cisneros, Jr. BCRX trade | |
| BuyJoint | $1,001 – $15,000 | Oct 16, 2023 | Filing for Josh Gottheimer BCRX trade | |
| SellJoint | $1,001 – $15,000 | Sep 15, 2023 | Filing for Josh Gottheimer BCRX trade | |
| BuyJoint | $1,001 – $15,000 | Aug 11, 2022 | Filing for Josh Gottheimer BCRX trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell BCRX. How Congress trading data works